explore -WSS

explore

author：hotspot 2025-09-27 09:47:14 - browse：65644

Adam's take main illustration — Molly Ferguson/STAT

Cassava Sciences has long claimed its experimental drug, called simufilam, slows the cognitive decline of people with Alzheimer’s. On Friday, we learned how: The company recruited a large number of people into its clinical trial who don’t have Alzheimer’s.

People who almost certainly had Alzheimer’s were also included in the study, but in this group, a placebo outperformed Cassava’s drug.

The conclusion, of course, is obvious: Simufilam is inactive. It’s an inert compound no more effective than a placebo. Cassava’s assertion that simufilam is showing “disease-modifying activity” falls apart given its study was opened to people who should have been ineligible because they were misdiagnosed with Alzheimer’s. Whether that was done intentionally or unwittingly isn’t known, but it’s certainly troubling and makes the case for immediate, regulatory intervention even stronger.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Researchers use wearables data and AI to predict preterm birth risk

entertainment

WSS

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

How the Dana

Covid vaccines: Private market messier than government rollout

'The Exorcist' director William Friedkin dead at 87

In medicine, common shorthands can shortchange care

Medicare drug price negotiation program allowed for now

knowledge

explore

explore

Hollywood unions extend contract negotiations for actors

Biogen shutters digital health group, ends Apple study, in cost cutting move

23andMe had bad news about my health. I wish a person had delivered it

Mississippi candidates for statewide offices square off in party primaries

Supreme Court strikes down use of affirmative action

Researchers use wearables data and AI to predict preterm birth risk

Supreme Court strikes down use of affirmative action

Why do women spend more than men on medical expenses?

New air purifier tech could be key to improving indoor air quality

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

knowledge

Paxlovid should be available without a positive Covid test

Inequities make cancer less preventable for women: report

Illinois to ban advertising for guns allegedly marketed to kids and militants

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

The UK government moves asylum

Would Medicare drug price negotiations stall in a shutdown?

focus

entertainment

hotspot

Wikipedia